NM_000314.8:c.-9C>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: PTEN c.-9C>G (NC_000010.10:g.89624218C>G) meets criteria to be classified as benign for PTEN Hamartoma Tumor syndrome in an autosomal dominant manner using modified ACMG criteria (Mester et al. 2018; manuscript in preparation). Please see a summary of the rules and criteria codes in the “PTEN ACMG Specifications Summary” document (assertion method column).BA1: Allele frequency of 0.048 (4.8%, 903/18,870 alleles) in the East Asian subpopulation of the gnomAD cohort. (PMID 27535533) LINK:https://erepo.genome.network/evrepo/ui/classification/CA000663/MONDO:0017623/003

Frequency

Genomes: 𝑓 0.0020 ( 10 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 43 hom. )

Consequence

PTEN
NM_000314.8 5_prime_UTR

Scores

2

Clinical Significance

Benign reviewed by expert panel B:20

Conservation

PhyloP100: 2.55

Publications

31 publications found
Variant links:
Genes affected
PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]
PTEN Gene-Disease associations (from GenCC):
  • Cowden syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • PTEN hamartoma tumor syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • macrocephaly-autism syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Genomics England PanelApp, Orphanet
  • renal cell carcinoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • leiomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • activated PI3K-delta syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Bannayan-Riley-Ruvalcaba syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Cowden disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lhermitte-Duclos disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Proteus-like syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • glioma susceptibility 2
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000314.8. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
NM_000314.8
MANE Select
c.-9C>G
5_prime_UTR
Exon 1 of 9NP_000305.3
PTEN
NM_001304717.5
c.511C>Gp.Leu171Val
missense
Exon 2 of 10NP_001291646.4
PTEN
NM_001304718.2
c.-714C>G
5_prime_UTR
Exon 1 of 9NP_001291647.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTEN
ENST00000371953.8
TSL:1 MANE Select
c.-9C>G
5_prime_UTR
Exon 1 of 9ENSP00000361021.3P60484-1
PTEN
ENST00000693560.1
c.511C>Gp.Leu171Val
missense
Exon 2 of 10ENSP00000509861.1A0A8I5KSF9
PTEN
ENST00000700029.2
c.-9C>G
5_prime_UTR
Exon 1 of 10ENSP00000514759.2A0A8V8TPK6

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
311
AN:
152220
Hom.:
10
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0529
Gnomad SAS
AF:
0.00352
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00382
AC:
961
AN:
251482
AF XY:
0.00349
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0473
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00148
AC:
2164
AN:
1461106
Hom.:
43
Cov.:
30
AF XY:
0.00145
AC XY:
1057
AN XY:
726880
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33468
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0419
AC:
1663
AN:
39694
South Asian (SAS)
AF:
0.00241
AC:
208
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53406
Middle Eastern (MID)
AF:
0.000569
AC:
3
AN:
5270
European-Non Finnish (NFE)
AF:
0.000118
AC:
131
AN:
1111862
Other (OTH)
AF:
0.00262
AC:
158
AN:
60330
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
133
266
398
531
664
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00205
AC:
312
AN:
152338
Hom.:
10
Cov.:
32
AF XY:
0.00250
AC XY:
186
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41568
American (AMR)
AF:
0.000196
AC:
3
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.0533
AC:
276
AN:
5182
South Asian (SAS)
AF:
0.00352
AC:
17
AN:
4826
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68030
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
17
34
51
68
85
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000203
Hom.:
0
Bravo
AF:
0.00251
Asia WGS
AF:
0.0160
AC:
55
AN:
3478
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
4
Cowden syndrome 1 (4)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
PTEN hamartoma tumor syndrome (3)
-
-
2
not provided (2)
-
-
1
Breast and/or ovarian cancer (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
20
DANN
Benign
0.94
PhyloP100
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=222/78
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11202592; hg19: chr10-89624218; COSMIC: COSV64295334; COSMIC: COSV64295334; API